Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Corcept Therapeutics (CORT) EPS (Basic): 2009-2024

Historic EPS (Basic) for Corcept Therapeutics (CORT) over the last 12 years, with Dec 2024 value amounting to $1.35.

  • Corcept Therapeutics' EPS (Basic) fell 57.78% to $0.19 in Q3 2025 from the same period last year, while for Sep 2025 it was $1, marking a year-over-year decrease of 26.47%. This contributed to the annual value of $1.35 for FY2024, which is 32.35% up from last year.
  • Corcept Therapeutics' EPS (Basic) amounted to $1.35 in FY2024, which was up 32.35% from $1.02 recorded in FY2023.
  • Corcept Therapeutics' 5-year EPS (Basic) high stood at $1.35 for FY2024, and its period low was $0.92 during FY2020.
  • For the 3-year period, Corcept Therapeutics' EPS (Basic) averaged around $1.11, with its median value being $1.02 (2023).
  • Its EPS (Basic) has fluctuated over the past 5 years, first fell by 2.06% in 2022, then surged by 32.35% in 2024.
  • Yearly analysis of 5 years shows Corcept Therapeutics' EPS (Basic) stood at $0.92 in 2020, then rose by 5.43% to $0.97 in 2021, then fell by 2.06% to $0.95 in 2022, then grew by 7.37% to $1.02 in 2023, then surged by 32.35% to $1.35 in 2024.